Skip to main content
Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
21.21
+1.52 (7.72%)
Mar 9, 2026, 2:34 PM EDT - Market open

Denali Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
503
Market Cap
3.36B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023330.53M222.07M204.74%
Dec 31, 2022108.46M59.80M122.90%
Dec 31, 202148.66M-287.00M-85.50%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Catalyst Pharmaceuticals 588.99M
Tarsus Pharmaceuticals 451.36M
Arcutis Biotherapeutics 376.07M
IDEAYA Biosciences 218.71M
Viridian Therapeutics 70.85M
NewAmsterdam Pharma Company 22.50M
Xenon Pharmaceuticals 7.50M
Dianthus Therapeutics 3.08M
Revenue Rankings

DNLI News

More News